Tilray Brands, Inc.

Tilray Brands, Inc. is a cannabis-focused company based in the US, engaged in the production, distribution, and development of cannabis and wellness products to meet the needs of medical and recreational consumers. Founded in 2013 and headquartered in New York, US, Tilray Brands, Inc. specializes in cannabis products, with a focus on both medical and recreational use.

The company has not undergone significant pivots in strategy and does not have reported subsidiaries. The founder's history is not detailed, nor are any previous ventures. Tilray has secured funding through two rounds, with the most recent funding round being completed on December 31, 2025, marking the total amount raised at that time. Tilray Brands, Inc.

is a global leader in the cannabis and wellness sectors, specializing in the production and distribution of a wide range of cannabis-derived products. Their core product offerings include medical cannabis products aimed at patients requiring therapeutic solutions, as well as recreational cannabis products for adult consumers. Products address various health conditions, including pain management, anxiety, and sleep disorders, with a focus on providing high-quality, safe, and effective options. Tilray also develops wellness products, including CBD-infused items tailored for consumers seeking natural alternatives for health and wellness.

The company primarily serves markets in Canada and the United States, with additional expansion into European markets, including Germany and the United Kingdom, ensuring compliance with local regulatory requirements. Tilray generates revenue through the sale of its diverse cannabis products, utilizing a multi-channel distribution strategy. Transactions occur primarily through direct-to-consumer sales from its medical and recreational use websites, as well as via partnerships with licensed retailers and wholesalers. The company focuses on subscription models for patients on medical cannabis, allowing for recurring orders tailored to individual health needs.

Retailers offer Tilray's flagship products, which may include trademarked cannabis brands, through physical dispensaries across various regions, facilitating a steady revenue stream driven by increasing consumer demand in both medical and recreational cannabis markets. In the fourth quarter of 2025, Tilray Brands, Inc. plans to expand its product offerings with new cannabis wellness products aimed at enhancing consumer health options. The company is targeting further expansion into European markets, specifically Germany and the United Kingdom, to increase its footprint by the end of 2025.

Recent investments from Zurcher Kantonalbank and Wealth Enhancement Advisory Services in the PIPE deal will support these initiatives, helping to fund the development and marketing of new product lines as well as the expansion into new regions.